400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Epigenetics / PARP / Rucaparib camsylate
CAS No.: 1327258-57-0
Synonyms: AG014699 camsylate;PF-01367338 camsylate
PARP inhibitor
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT02986100 | Solid Tumor | Phase 1 | Active, not recruiting | December 2018 | Hungary ... more >> PRA Magyarország Kft. Budapest, Rottenbiller Utca 13, Hungary, 1077 Collapse << |
NCT02740712 | Neoplasms | Phase 1 | Active, not recruiting | May 2019 | Poland ... more >> BioVirtus Research Site Kajetany, Mokra 7, Poland, 05-830 Med Polonia Poznan, Poland, 60-693 Zachodniopomorskie Centrum Onkologii Centrum Innowacji Szczecin, Poland, 71-730 Collapse << |
NCT03521037 | Neoplasms | Phase 1 | Recruiting | December 1, 2019 | Czechia ... more >> Onkologicka klinika VFN a 1. LF UK Recruiting Praha, Czechia, 128 08 Contact: Milada Zemanova Pharmaceutical Research Associates CZ Recruiting Praha, Czechia, 170 00 Contact: Milada Zemanova Poland Wojewódzki Szpital Specjalistyczny w Białej Podlaskiej Recruiting Biała Podlaska, Poland, 21-500 Contact: Piotr Centkowski Med Polonia Sp. z o.o. Recruiting Poznań, Poland, 60-693 Contact: Rodryg Ramlau Zachodniopomorskie Centrum Onkologii w Szczecinie Recruiting Szczecin, Poland, 71-730 Contact: Dorota Nowak BioVirtus Centrum Medyczne Recruiting Warszawa, Poland, 02-681 Contact: Monika Tomaszewska-Kiecana, MD 48 22 545.84.64 Slovakia Summit Clinical Research s.r.o. Recruiting Bratislava, Slovakia, 831 01 Contact: Miriam Drahokoupilova United Kingdom Northern Centre for Cancer Care Recruiting Newcastle Upon Tyne, United Kingdom, NE7 7DN Contact: Yvette Drew Collapse << |
实验方案
技术信息
CAS号 | 1327258-57-0 | 储存条件 |
|
|
分子式 | C29H34FN3O5S | 运输 | 蓝冰 | |
分子量 | 555.66 | 别名 | AG014699 camsylate;PF-01367338 camsylate |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT02986100 | Solid Tumor | Phase 1 | Active, not recruiting | December 2018 | Hungary ... more >> PRA Magyarország Kft. Budapest, Rottenbiller Utca 13, Hungary, 1077 Collapse << |
NCT02740712 | Neoplasms | Phase 1 | Active, not recruiting | May 2019 | Poland ... more >> BioVirtus Research Site Kajetany, Mokra 7, Poland, 05-830 Med Polonia Poznan, Poland, 60-693 Zachodniopomorskie Centrum Onkologii Centrum Innowacji Szczecin, Poland, 71-730 Collapse << |
NCT03521037 | Neoplasms | Phase 1 | Recruiting | December 1, 2019 | Czechia ... more >> Onkologicka klinika VFN a 1. LF UK Recruiting Praha, Czechia, 128 08 Contact: Milada Zemanova Pharmaceutical Research Associates CZ Recruiting Praha, Czechia, 170 00 Contact: Milada Zemanova Poland Wojewódzki Szpital Specjalistyczny w Białej Podlaskiej Recruiting Biała Podlaska, Poland, 21-500 Contact: Piotr Centkowski Med Polonia Sp. z o.o. Recruiting Poznań, Poland, 60-693 Contact: Rodryg Ramlau Zachodniopomorskie Centrum Onkologii w Szczecinie Recruiting Szczecin, Poland, 71-730 Contact: Dorota Nowak BioVirtus Centrum Medyczne Recruiting Warszawa, Poland, 02-681 Contact: Monika Tomaszewska-Kiecana, MD 48 22 545.84.64 Slovakia Summit Clinical Research s.r.o. Recruiting Bratislava, Slovakia, 831 01 Contact: Miriam Drahokoupilova United Kingdom Northern Centre for Cancer Care Recruiting Newcastle Upon Tyne, United Kingdom, NE7 7DN Contact: Yvette Drew Collapse << |
NCT03552471 | BRCA1 Gene Mutation ... more >> BRCA2 Gene Mutation Folate Receptor Alpha Positive Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Recurrent Uterine Corpus Carcinoma Recurrent Uterine Serous Carcinoma Recurrent Uterine Carcinosarcoma Platinum Resistant Ovarian Cancer Collapse << | Phase 1 | Recruiting | August 29, 2021 | United States, Ohio ... more >> Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Floor Backes, MD 614-293-3873 Principal Investigator: Floor Backes Collapse << |
NCT03442556 | ATM Gene Mutation ... more >> BRCA1 Gene Mutation BRCA2 Gene Mutation Castration Levels of Testosterone Castration-Resistant Prostate Carcinoma Homologous Recombination Deficiency Prostate Carcinoma Metastatic in the Bone PSA Level Greater Than or Equal to Two PSA Progression Stage IV Prostate Adenocarcinoma AJCC v7 Collapse << | Phase 2 | Recruiting | May 15, 2024 | United States, Washington ... more >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Heather H. Cheng 206-606-1406 hhcheng@uw.edu Principal Investigator: Heather H. Cheng Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网